Product Information
SULFASALAZINE 500 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.1975 per EA under NDC 00093323401. Its NADAC has been published 180 times since Jan 18, 2023.
Strength
500 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093323401
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
SULFASALAZINEApproval Type
Generic (ANDA)
FDA Application
ANDA085828On Market Since
12/15/2022
Pharmacological Classes
Price Statistics
The NADAC for SULFASALAZINE 500 MG TABLET has been published 180 times since Jan 18, 2023, and over the history we have for it it has risen 23.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1975 per EA |
|---|---|
| All-time high | $0.1975 (Jun 24, 2026) |
| All-time low | $0.1285 (Apr 17, 2024) |
| 52-week high | $0.1975 |
| 52-week low | $0.1777 |
| Median price | $0.1777 |
| Average price | $0.1728 |
| Largest weekly change | +31.0% (Aug 21, 2024) |
| Weeks tracked | 180 |
| Tracking since | Jan 18, 2023 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of SULFASALAZINE 500 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SULFASALAZINE 500 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.1975 per EA (NDC 00093323401), effective Jun 24, 2026.
How has the price of SULFASALAZINE 500 MG TABLET changed over time?
Over the history we have for it, the NADAC for SULFASALAZINE 500 MG TABLET has risen 23.4%. It has been tracked across 180 weekly CMS publications since Jan 18, 2023.
What are the highest and lowest recorded NADAC prices for SULFASALAZINE 500 MG TABLET?
Since Jan 18, 2023, the NADAC for SULFASALAZINE 500 MG TABLET has ranged from a low of $0.1285 (Apr 17, 2024) to a high of $0.1975 (Jun 24, 2026), with a median of $0.1777 per EA.
Are there cheaper alternatives to SULFASALAZINE 500 MG TABLET?
4 NADAC-published products share the same active ingredient, strength, and dosage form as SULFASALAZINE 500 MG TABLET, but none are currently priced below it.
Who manufactures SULFASALAZINE 500 MG TABLET?
SULFASALAZINE 500 MG TABLET (NDC 00093323401) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification